Liquid biopsy for lung transplant damage classification
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests a simple blood test (liquid biopsy) to detect and classify damage to a transplanted lung. It aims to find signs of rejection or injury earlier, which could help doctors treat problems sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have received a lung transplant and are being followed at one of the study centers.
- You can understand and read the consent form in the languages used by the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for lab “clues” that can help predict how well someone’s lungs will do after a lung transplant. It may help doctors spot transplant-related problems earlier so care can be planned sooner.
This study looks at whether a specialized blood test can help doctors better assess lung cancer. It may be helpful if you are an adult who can safely participate and provide a sample for testing.
This study uses a simple blood test (liquid biopsy) to find early signs of lung cancer in people who are at risk. It aims to catch lung cancer earlier, when it may be easier to treat.
This study uses advanced blood and tissue testing to predict how well a new lung will work after transplant. If you've had a lung transplant and are stable, you may help researchers improve care for future patients.
This trial uses a simple blood test (liquid biopsy) to find tumor DNA in people suspected of having lung cancer. The goal is to learn if this test can help doctors make better treatment decisions without needing a tissue sample.
This study tests whether a blood test (liquid biopsy) can help doctors better understand your lung cancer and plan your treatment. You'll have a blood sample taken alongside standard biopsies to see if the blood test provides useful information about your cancer.
Hear when a new Lung Transplant Failure and Rejection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.